|
|
Press Releases
Dainippon Sumitomo Pharma Co., Ltd. and Boston Biomedical, Inc . Enter Strategic Partnership on Anti-Cancer Drugs
Targeting Cancer Stem Cells
First-In-Class Drug BBI608 Tested in Patients with Advanced Cancer
Next Generation RNAi Technology Discovered
by AiRNA Pharmaceuticals and Boston
Biomedical Published in Nature Biotechnology
ArQule spins out Boston Biomedical with $5M research deal
ArQule discovery arm carries on as Boston Biomedical
Business Conferences
Science Conferences
|
|
